FROM SFLA NEWS

Students for Life Again Supports Louisiana’s Case Against the FDA with an Amicus Brief, As Chemical Abortion Pill Policy to be Debated before the Fifth Circuit

Image
Olivia D'Angelo - 08 Sep 2026

MEDIA ADVISORY: Louisiana v. FDA to be argued in the Fifth Circuit Court of Appeals on September 9, 2026.

“Louisiana again confronts the dangers of chemical abortion pills in court, and those risks include threats to endangered species, which we detailed in our amicus brief,” said Students for Life’s Kristan Hawkins. “A peer-reviewed study shows that mifepristone and mifepristone equivalents taint the water where it was tested. The risk to the fertility of human beings and wildlife exposed to mifepristone-poisoned water and the harms of chemical abortion pills to preborn babies combine to demand that the FDA finally act to help protect LIFE and not an abortion-distribution model.”

For interviews, contact [email protected].

WASHINGTON, D.C. (09-08-2026) – Students for Life of America (SFLA) President Kristan Hawkins saluted Louisiana’s “heroic work” in again going up against abortion pill profiteers as Louisiana v. the Food & Drug Administration (FDA) goes back before the Fifth Circuit Court of Appeals. SFLA submitted an amicus brief in June asking the judges to take seriously the immeasurable damage the reckless policies regulating chemical abortion pills may have had on endangered species and the failure to follow the law when dumping pills on the market. The “Endangered Species Act” demands proof that endangered species won’t be harmed by a policy, which in this case is the reckless approval and distribution of chemical abortion pills resulting today in tons of chemically tainted blood, placenta tissue, along with human remains, and mifepristone-tainted feces and urine, all going into America’s waterways.

“Chemical abortion pills destroy innocent lives in the womb, and we have reason to believe that mifepristone and mifepristone-equivalents in the water can also impact the heath and fertility of men, women, and children,” said Hawkins. “But remember, the nearly 1,500 endangered species at risk can’t run out and buy a water filter. The law in place to protect their interests and their very lives has been ignored.”  

CLICK HERE TO READ THE AMICUS BRIEF.

A recently released, peer-reviewed water study at Issues in Law & Medicine, a Journal of the Alliance for Hippocratic Medicine (JAHM), titled: “Anti-Progesterone in Environmental Water” found that mifepristone and mifepristone equivalents are in the water. 

Elise Rose, PhD, anchored the study and noted when it was released: “Because of the importance of progesterone for human and animal health, the presence of anti-progesterone in environmental and tap water poses potential health risks. Everyone should be concerned that we are possibly being exposed to an endocrine-disrupting compound without our consent.” 

As previously reported by SFLA: 

Our brief notes that there are nearly 1,500 endangered species in the U.S. that “depend on ecosystems within the United States that are impacted by human activity. Amicus SFLA and its members are concerned that the failure of the FDA to conduct consultation with the Services has led to irreparable harm to listed species and habitats and may lead to the destruction of some of these species.” 

The legal analysis notes: “The FDA has a legal obligation to comply with the ESA. The consultation requirement reflects ‘a conscious decision by Congress to give endangered species priority over the ‘primary missions’ of federal agencies. The FDA’s actions on Mifepristone have failed to meet the requirements of the ESA and, therefore, must be revoked until the agency can implement measures to ensure that its actions do not adversely affect listed endangered or threatened species or designated critical habitats. Failure to do so could lead to the extinction of these species. This Court has the authority to order a federal agency to comply with the ESA.” 

It continues: “In a document entitled, ‘ENVIRONMENTAL ASSESSMENT AND FINDING OF NOT SIGNIFICANT IMPACT FOR NDA 20-687 MIFEPRISTONE TABLETS,’ the FDA stated without support that ‘[a]dverse effects are not anticipated upon endangered or threatened species.’ This conclusion runs afoul of the requirements of the ESA, relying upon numerous incorrect assumptions about how Mifepristone could enter the environment. Indeed, the FDA did not conduct an environmental study regarding the potential impact Mifepristone could have on the nation’s wastewater. The FDA reviewed only the impact that packaging, production waste, and pharmaceutical waste would have on the environment, failing to examine the impact the excretion of Mifepristone itself would have on the environment.2 Further, the assessment underestimated the number of chemical abortions due to Mifepristone, which are today the most popular form of abortion.” 

Environmentalists have also called on the federal government to address the FDA’s failure to protect endangered species from fertility-blocking abortion pill water pollution. 

For more information, or to schedule an interview, email [email protected].

####

The Pro-Life Generation (PLG) is an umbrella organization encompassing the most cutting-edge engagement opportunities for a Vote Pro-Life First Community. PLG includes Students for Life Action (SFLAction), a 501 (c) (4), along with its 501 (c) (3) sister organization, Students for Life of America (SFLA), that together make up the nation’s largest pro-life youth organization, managing a grassroots political and policy operation engaging Americans of all ages but with a special emphasis on the largest segment of voters — the Youth Vote. Headquartered in Fredericksburg, VA, PLG/SFLA/SFLAction serves more than 1,700 groups on middle, high school, college, medical, and law school campuses in all 50 states. Our team has more conversations with this generation targeted by the abortion lobby than any other pro-life operation in the world, each week reaching more than 4 million across social media platforms and averaging 1.3 million video views. In addition to SFLA/SFLAction, PLG leads multiple initiatives to lead and serve the future of the pro-life movement, including the Campaign for Abortion Free Cities, StandingWithYou, and the Demetree Institute for Pro-Life Advancement. Over 20 years, PLG CEO Kristan Hawkins has grown the operation into an early $20M organization, now preparing for an abortion-free America.

Share this post